Healthline: People are taking high doses of melatonin to sleep: Why experts are concerned
UC expert says taking too much melatonin could disrupt our sleep-wake cycle
According to a research letter published in the Journal of the American Medical Association, more people are taking supplemental melatonin, and at increasingly high doses. Researchers point out these findings raise safety concerns since the actual dose of melatonin supplements could be nearly 500% higher than the label indicates. In a story published by Healthline, Sarah Gallucci, DO, of the Division of Pulmonary, Critical Care and Sleep Medicine was one of the experts cited reacting to the letter.
Sarah Gallucci, DO, of the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine
“Melatonin is considered a dietary supplement and is not FDA approved for safety or effectiveness,” confirmed Sarah Gallucci, DO, an assistant professor of medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the UC College of Medicine.
She added that there is an organization that confirms the claimed dosage and purity of some brands.
“Supplements that are verified by the United States Pharmacopeial convention are the most reliable,” said Gallucci. “USP verified supplements are tested to ensure that the potency and amounts match the label and that the product does not contain harmful levels of specified contaminants.”
Gallucci added that melatonin is considered “generally safe,” with few serious adverse effects.
“The most common side effects are headache, dizziness, nausea, and fatigue,” she said.
Gallucci cautioned that taking too much melatonin could disrupt our sleep-wake cycle, making it more difficult to fall asleep.
“Safe starting doses range from 2 to 5 mg,” she advised. “Melatonin does not have any addictive potential, which can be seen with some prescription sleep medications.”
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
UC expands partnership with Thales for AI research
April 22, 2026
The University of Cincinnati’s interdisciplinary research facility Digital Futures welcomed its first industrial partner, Thales, at the beginning of Research + Innovation week. Thales is a global aerospace, defense and digital technology firm. Headquartered in France, it employs 83,000 people in dozens of countries, according to the Business Courier.
Record-setting UC track and field star sprints toward the future
April 22, 2026
University of Cincinnati student‑athlete Juliette Laracuente‑Huebner is graduating in three years with a 4.0 GPA, UC track and field records and All‑America honors, while pursuing a Doctor of Audiology and training for the 2028 Olympics in Los Angeles.
University of Cincinnati College of Medicine celebrates Class of 2026 at Honors Day
April 21, 2026
The UC College of Medicine celebrates the Class of 2026 at Honors Day. With a 100% residency match rate, 177 new MD, MD-PhD and MD-MPH graduates prepare for top-tier training nationwide.